DLA
Douglas Lane & Associates Portfolio holdings
AUM
$6.9B
This Quarter Return
+14.57%
1 Year Return
+13.87%
3 Year Return
+73.39%
5 Year Return
+145.47%
10 Year Return
–
AUM
$5.98B
AUM Growth
+$5.98B
(+11%)
Cap. Flow
-$11.7M
Cap. Flow
% of AUM
-0.2%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
234
New
18
Increased
64
Reduced
132
Closed
5
Top Buys
| 1 |
Haleon
HLN
|
$27.4M |
| 2 |
Freeport-McMoran
FCX
|
$24.3M |
| 3 |
Comcast
CMCSA
|
$21.9M |
| 4 |
Charter Communications
CHTR
|
$19.8M |
| 5 |
International Flavors & Fragrances
IFF
|
$16.9M |
Top Sells
| 1 |
Constellation Brands
STZ
|
$22.3M |
| 2 |
Chubb
CB
|
$21M |
| 3 |
Lowe's Companies
LOW
|
$17.8M |
| 4 |
Marathon Petroleum
MPC
|
$9.91M |
| 5 |
Danaher
DHR
|
$9.43M |
Sector Composition
| 1 | Financials | 19.44% |
| 2 | Healthcare | 16.02% |
| 3 | Technology | 15.43% |
| 4 | Industrials | 9.43% |
| 5 | Communication Services | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Gilead Sciences
GILD
$140B
| $284K | ﹤0.01% |
+3,308
| New | +$284K |
|
202
Goldman Sachs
GS
$226B
| $281K | ﹤0.01% |
817
+1
| +0.1% | +$343 |
|
203
Intuit
INTU
$186B
| $279K | ﹤0.01% |
+717
| New | +$279K |
|
204
Dow Inc
DOW
$17.5B
| $267K | ﹤0.01% |
5,308
| – | – |
|
205
CSX Corp
CSX
$60.6B
| $265K | ﹤0.01% |
8,549
| – | – |
|
206
Corteva
CTVA
$50.4B
| $262K | ﹤0.01% |
4,464
+90
| +2% | +$5.29K |
|
207
Cognizant
CTSH
$35.3B
| $257K | ﹤0.01% |
4,500
| – | – |
|
208
Canadian Pacific Kansas City
CP
$69.9B
| $252K | ﹤0.01% |
3,378
| – | – |
|
209
Texas Instruments
TXN
$184B
| $251K | ﹤0.01% |
1,522
-141
| -8% | -$23.3K |
|
210
HCA Healthcare
HCA
$94.5B
| $250K | ﹤0.01% |
+1,040
| New | +$250K |
|
211
General Dynamics
GD
$87.3B
| $247K | ﹤0.01% |
+997
| New | +$247K |
|
212
AGNC Investment
AGNC
$10.2B
| $239K | ﹤0.01% |
+23,100
| New | +$239K |
|
213
Charles Schwab
SCHW
$174B
| $237K | ﹤0.01% |
+2,847
| New | +$237K |
|
214
Fortune Brands Innovations
FBIN
$7.02B
| $230K | ﹤0.01% |
4,026
-17,600
| -81% | -$1.01M |
|
215
Linde
LIN
$224B
| $224K | ﹤0.01% |
+688
| New | +$224K |
|
216
Hubbell
HUBB
$22.9B
| $223K | ﹤0.01% |
950
| – | – |
|
217
Brown-Forman Class B
BF.B
$14.2B
| $220K | ﹤0.01% |
3,345
-30
| -0.9% | -$1.97K |
|
218
Lockheed Martin
LMT
$106B
| $205K | ﹤0.01% |
+420
| New | +$205K |
|
219
Geron
GERN
$893M
| $203K | ﹤0.01% |
+83,900
| New | +$203K |
|
220
TJX Companies
TJX
$152B
| $202K | ﹤0.01% |
+2,538
| New | +$202K |
|
221
Transact Technologies
TACT
$43.8M
| $76.4K | ﹤0.01% |
12,081
| – | – |
|
222
Aurinia Pharmaceuticals
AUPH
$1.58B
| $52.7K | ﹤0.01% |
+12,200
| New | +$52.7K |
|
223
Heron Therapeutics
HRTX
$207M
| $25K | ﹤0.01% |
+10,000
| New | +$25K |
|
|
ADAP
224
Adaptimmune Therapeutics
ADAP
$15.6M
| $19K | ﹤0.01% |
+13,000
| New | +$19K |
|
|
LQMT
225
DELISTED
LIQUIDMETAL TECHNOLOGIES INC
LQMT
| $636 | ﹤0.01% |
10,000
| – | – |
|